Actos® is a drug that can treat diabetes, but studies show that the drug may significantly increase the chances of patients developing bladder cancer. Unfortunately, the risk wasn’t communicated to many patients who took the drug.
As a result, patients who developed bladder cancer after taking Actos filed drug injury lawsuits against the manufacturer of Actos, Takeda Pharmaceutical. Several of those cases went to trial with mixed results. And now Takeda has announced that it wishes to settle a majority of the remaining Actos drug injury lawsuits for an estimated $2.4 billion.
According to The New York Times, the settlement will only be finalized if 95 percent of the plaintiffs who qualify agree to the terms of the offer. The cutoff for victims to submit their approval or denial is mid-July. If the settlement is finalized, victims can expect to see payments up to $296,000 each.